Bronchoalveolar CD4+ T cell responses to respiratory antigens are impaired in HIV-infected adults

Thorax

Volumn 66, Issue 5, 2011, Pages 375-382

  Jambo, Kondwani C ^a,b   Sepako, Enoch ^a,b,c   Fullerton, Duncan G ^a   Mzinza, David ^b   Glennie, Sarah ^b   Wright, Adam K ^a,d   Heyderman, Robert S ^b   Gordon, Stephen B ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF MALAWI   (Malawi)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN;

ADULT; ANTIGEN DETECTION; ANTIGEN FUNCTION; ARTICLE; BLOOD ANALYSIS; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFLUENZA VIRUS; LUNG LAVAGE; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY T LYMPHOCYTE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STREPTOCOCCUS PNEUMONIAE;

EID: 79955000453     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.153825     Document Type: Article

References (31)

1. Mathers C, Boerma T, Ma Fat D. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: World Health Organisation, 2008.
2. Mukadi YD, Maher D, Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS 2001;15:143-52. (Pubitemid 32142288)
3. Turner D. Improving Global Health by Preventing Pneumococcal Disease. In: APPG, ed. London, United Kingdom: UK Government, 2008:1-35.
4. UNAIDS. AIDS Epidemic Update: November 2009. Geneva, Switzerland: UNAIDS WH0, 2009.
5. van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009;374:1543-56.
6. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009;27:393-422.
7. Malley R. Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development. J Mol Med 2010;88:135-42.
8. Thomas PG, Keating R, Hulse-Post DJ, et al. Cell-mediated protection in influenza infection. Emerg Infect Dis 2006;12:48-54. (Pubitemid 43143535)
9. Dalton DK, Pitts-Meek S, Keshav S, et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993;259:1739-42. (Pubitemid 23114658)
10. Laan M, Cui ZH, Hoshino H, et al. Neutrophil recruitment by human IL-17 Via C-X-C chemokine release in the airways. J Immunol 1999;162:2347-52. (Pubitemid 29288861)
11. Scriba TJ, Kalsdorf B, Abrahams DA, et al. Distinct, specific IL-17-and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 2008;180:1962-70.
12. Wilson EB, Livingstone AM. Cutting edge: CD4+ T cell-derived IL-2 is essential for help-dependent primary CD8+ T cell responses. J Immunol 2008;181:7445-8.
13. de Bree GJ, Daniels H, Schilfgaarde M, et al. Characterization of CD4+ memory T cell responses directed against common respiratory pathogens in peripheral blood and lung. J Infect Dis 2007;195:1718-25. (Pubitemid 46799231)
14. Barry SM, Lipman MC, Bannister B, et al. Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and nonpulmonary tuberculosis. J Infect Dis 2003;187:243-50. (Pubitemid 36132637)
15. Brenchley JM, Knox KS, Asher AI, et al. High frequencies of polyfunctional HIV-specific T cells are associated with preservation of mucosal CD4 T cells in bronchoalveolar lavage. Mucosal Immunol 2008;1:49-58.
16. Jordano Q, Falcón V, Almirante B, et al. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis 2004;38:1623-8. (Pubitemid 38738561)
17. Sonnenberg P, Glynn JR, Fielding K, et al. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis 2005;191:150-8. (Pubitemid 40096371)
18. Gordon SB, Malamba R, Mthunthama N, et al. Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses. Vaccine 2008;26:5400-6.
19. Sallusto F, Lenig D, Forster R, et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-12.
20. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003;4:330-6. (Pubitemid 36432314)
21. Kalsdorf B, Scriba TJ, Wood K, et al. HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria. Am J Respir Crit Care Med 2009;180:1262-70.
22. Bakocevic N, Worbs T, Davalos-Misslitz A, et al. T cell-dendritic cell interaction dynamics during the induction of respiratory tolerance and immunity. J Immunol 2010;184:1317-27.
23. Hazenberg MD, Otto SA, van Benthem BH, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003;17:1881-8. (Pubitemid 37070273)
24. Kolte L, Gaardbo JC, Skogstrand K, et al. Increased levels of regulatory T cells (Tregs) in human immunodeficiency virus-infected patients after 5 years of highly active anti-retroviral therapy may be due to increased thymic production of naive Tregs. Clin Exp Immunol 2009;155:44-52.
25. Geldmacher C, Ngwenyama N, Schuetz A, et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med 2010;207:2869-81.
26. Lin JC, Nichol KL Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med 2001;161:441-6. (Pubitemid 32116562)
27. Sutherland JS, Young JM, Peterson KL, et al. Polyfunctional CD4 (+) and CD8 (+) T cell responses to tuberculosis antigens in HIV-1-infected patients before and after anti-retroviral treatment. J Immunol 2010;184:6537-44.
28. Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection implications for vaccine design. Nat Rev Immunol 2008;8:247-58. (Pubitemid 351432801)
29. Darrah PA, Patel DT, De Luca PM, et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007;13:843-50. (Pubitemid 47038186)
30. Forbes EK, Sander C, Ronan EO, et al. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol 2008;181:4955-64.
31. Nebbia G, Mattes FM, Smith C, et al. Polyfunctional cytomegalovirus- specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation. Am J Transplant 2008;8:2590-9.